Shandong Weigao Group Medical Polymer Company Limited

Symbol: SHWGF

PNK

0.9575

USD

Market price today

  • 15.4080

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 4.33B

    MRK Cap

  • 0.02%

    DIV Yield

Shandong Weigao Group Medical Polymer Company Limited (SHWGF) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.48%

Operating Profit Margin

0.17%

Net Profit Margin

0.15%

Return on Assets

0.06%

Return on Equity

0.09%

Return on Capital Employed

0.09%

Company general description and statistics

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO:Mr. Rinan Cong
Full-time employees:12333
City:Weihai
Address:Torch Hi-Tech Science Park
IPO:2010-06-08
CIK:

Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.

General Outlook

When we look at how much money they make before expenses, they keep 0.482% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.168%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.152%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.060% return, is a testament to Shandong Weigao Group Medical Polymer Company Limited's adeptness in optimizing resource deployment. Shandong Weigao Group Medical Polymer Company Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.092%. Furthermore, the proficiency of Shandong Weigao Group Medical Polymer Company Limited in capital utilization is underscored by a remarkable 0.085% return on capital employed.

Stock Prices

Shandong Weigao Group Medical Polymer Company Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.73, while its low point bottomed out at $1.73. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shandong Weigao Group Medical Polymer Company Limited's stock market.

Liquidity Ratios

Analyzing SHWGF liquidity ratios reveals its financial health of the firm. The current ratio of 245.77% gauges short-term asset coverage for liabilities. The quick ratio (203.92%) assesses immediate liquidity, while the cash ratio (102.13%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio245.77%
Quick Ratio203.92%
Cash Ratio102.13%

Profitability Ratios

SHWGF profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 17.40% underscores its earnings before tax deductions. The effective tax rate stands at 13.48%, revealing its tax efficiency. The net income per EBT, 87.26%, and the EBT per EBIT, 103.58%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 16.80%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin17.40%
Effective Tax Rate13.48%
Net Income per EBT87.26%
EBT per EBIT103.58%
EBIT per Revenue16.80%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.46, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 180.03% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding204
Days of Inventory Outstanding132
Operating Cycle335.11
Days of Payables Outstanding61
Cash Conversion Cycle274
Receivables Turnover1.80
Payables Turnover5.95
Inventory Turnover2.76
Fixed Asset Turnover1.81
Asset Turnover0.39

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.08, and free cash flow per share, 0.08, depict cash generation on a per-share basis. The cash per share value, 0.25, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.18, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.08
Free Cash Flow per Share0.08
Cash per Share0.25
Operating Cash Flow Sales Ratio0.18
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio0.52
Short Term Coverage Ratio0.77
Dividend Payout Ratio0.17

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 13.90%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.21, we discern the balance between debt and equity financing. The long-term debt to capitalization, 6.24%, and total debt to capitalization, 17.25%, ratios shed light on its capital structure. An interest coverage of 8.15 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio13.90%
Debt Equity Ratio0.21
Long Term Debt to Capitalization6.24%
Total Debt to Capitalization17.25%
Interest Coverage8.15
Cash Flow to Debt Ratio0.52
Company Equity Multiplier1.50

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.42, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.06, reflects the portion of profit attributed to each share. The book value per share, 0.70, represents the net asset value distributed per share, while the tangible book value per share, 0.30, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.42
Net Income Per Share0.06
Book Value Per Share0.70
Tangible Book Value Per Share0.30
Shareholders Equity Per Share0.70
Interest Debt Per Share0.21
Capex Per Share-0.02

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,910,006,713, captures the company's total value, considering both debt and equity. Income quality, 1.25, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.67, gauges operational efficiency, while the research and development to revenue, 4.48%, highlights investment in innovation. The ratio of intangibles to total assets, 110.30%, indicates the value of non-physical assets, and capex to operating cash flow, -27.50%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value3,910,006,713
Income Quality1.25
Sales General and Administrative to Revenue0.67
Research and Development to Revenue4.48%
Intangibles to Total Assets110.30%
Capex to Operating Cash Flow-27.50%
Capex to Revenue-5.18%
Capex to Depreciation-75.65%
Stock-Based Compensation to Revenue2.96%
Graham Number1.00
Return on Tangible Assets-57.93%
Graham Net Net0.16
Working Capital1,557,944,086
Tangible Asset Value-1,844,619,758
Net Current Asset Value1,271,015,393
Average Receivables1,027,933,428.5
Average Payables185,228,068.5
Average Inventory342,257,312
Days Sales Outstanding203
Days Payables Outstanding61
Days of Inventory On Hand132
ROIC7.24%
ROE0.09%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.38, and the price to book ratio, 1.38, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.31, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 12.58, and price to operating cash flows, 12.71, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.38
Price to Book Ratio1.38
Price to Sales Ratio2.31
Price Cash Flow Ratio12.71
Enterprise Value Multiple10.74
Price Fair Value1.38
Price to Operating Cash Flow Ratio12.71
Price to Free Cash Flows Ratio12.58
Price to Tangible Book Ratio1.37
Enterprise Value to Sales2.09
Enterprise Value Over EBITDA8.73
EV to Operating Cash Flow11.08
Earnings Yield6.54%
Free Cash Flow Yield5.91%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Shandong Weigao Group Medical Polymer Company Limited (SHWGF) on the PNK in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 15.408 in 2024.

What is the ticker symbol of Shandong Weigao Group Medical Polymer Company Limited stock?

The ticker symbol of Shandong Weigao Group Medical Polymer Company Limited stock is SHWGF.

What is company IPO date?

IPO date of Shandong Weigao Group Medical Polymer Company Limited is 2010-06-08.

What is company current share price?

Current share price is 0.958 USD.

What is stock market cap today?

The market cap of stock today is 4330130975.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 12333.